HP API containment upgrade
Minakem has initiated an ambitious investment plan for setting up equipments with the highest level of containment required to develop and produce highly potent molecules such as Antibody-drug conjugates toxins. The investments will enable Minakem to handle High...
Minafin receives the Global Enterprise prize
In 2017, as the awards celebrate their 25th edition, EY & partners celebrate the exceptional stories of entrepreneurs who are instrumental in France’s economic growth and competitiveness. In his acceptance speech, Frédéric Gauchet, President of Minafin Group, drew...
Minakem invests in Chromatography
Minakem, Minafin Group’s arm dedicated to the chemical development and manufacturing for the pharmaceutical industry, and the supply of associated services for the drug products, today announces that it has finalized the first phase of the commissioning of preparative...
The core of the Minafin group’s financial investors is being renewed
Mont-Saint-Guibert, 31 May 2017 The Minafin group now has a new pool of minority financial investors incorporating Edmond de Rothschild Investment Partners, Siparex, CM-CIC Investissement and Croissance Nord-Pas de Calais. Founded in 2004 by Frédéric Gauchet, Minafin...